{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360021394478764544.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1128/cmr.00130-18"}},{"identifier":{"@type":"URI","@value":"https://journals.asm.org/doi/pdf/10.1128/CMR.00130-18"}}],"dc:title":[{"@value":"Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p>Infections during pregnancy that may cause congenital abnormalities have been recognized for decades, but their diagnosis is challenging. This was again illustrated with the emergence of Zika virus (ZIKV), highlighting the inherent difficulties in estimating the extent of pre- and postnatal ZIKV complications because of the difficulties in establishing definitive diagnoses.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380021394478764550","@type":"Researcher","foaf:name":[{"@value":"Bettie Voordouw"}],"jpcoar:affiliationName":[{"@value":"Erasmus Medical Centre, Department of Viroscience, Rotterdam, The Netherlands"},{"@value":"State Institute of Public Health and Environment, Department of Infectious Disease Diagnostics, Research, and Laboratory Surveillance, Bilthoven, The Netherlands"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021394478764545","@type":"Researcher","foaf:name":[{"@value":"Barry Rockx"}],"jpcoar:affiliationName":[{"@value":"Erasmus Medical Centre, Department of Viroscience, Rotterdam, The Netherlands"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021394478764549","@type":"Researcher","foaf:name":[{"@value":"Thomas Jaenisch"}],"jpcoar:affiliationName":[{"@value":"Heidelberg University Hospital, Department for Infectious Diseases, Heidelberg, Germany"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021394478764546","@type":"Researcher","foaf:name":[{"@value":"Pieter Fraaij"}],"jpcoar:affiliationName":[{"@value":"Erasmus Medical Centre, Department of Viroscience, Rotterdam, The Netherlands"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021394478764547","@type":"Researcher","foaf:name":[{"@value":"Philippe Mayaud"}],"jpcoar:affiliationName":[{"@value":"London School of Hygiene and Tropical Medicine, Department of Clinical Research, London, United Kingdom"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021394478764544","@type":"Researcher","foaf:name":[{"@value":"Ann Vossen"}],"jpcoar:affiliationName":[{"@value":"Leiden University Medical Centre, Department of Medical Microbiology, Leiden, The Netherlands"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021394478764548","@type":"Researcher","foaf:name":[{"@value":"Marion Koopmans"}],"jpcoar:affiliationName":[{"@value":"Erasmus Medical Centre, Department of Viroscience, Rotterdam, The Netherlands"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"08938512"},{"@type":"EISSN","@value":"10986618"}],"prism:publicationName":[{"@value":"Clinical Microbiology Reviews"}],"dc:publisher":[{"@value":"American Society for Microbiology"}],"prism:publicationDate":"2019-12-18","prism:volume":"33","prism:number":"1","prism:startingPage":"e00130-18:1"},"reviewed":"false","dc:rights":["https://journals.asm.org/non-commercial-tdm-license"],"url":[{"@id":"https://journals.asm.org/doi/pdf/10.1128/CMR.00130-18"}],"createdAt":"2019-12-10","modifiedAt":"2022-02-23","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360865815514676736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Revision of Cytomegalovirus Immunoglobulin M Antibody Titer Cutoff in a Maternal Antibody Screening Program in Japan: A Cohort Comparison Involving a Total of 32,000 Pregnant Women"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1128/cmr.00130-18"},{"@type":"CROSSREF","@value":"10.3390/v15040962_references_DOI_FAjqWVo8h4EvnlxcqrVpBdjOVmo"}]}